There is evidence that β-amyloid, a hallmark of Alzheimer's disease, can interfere with insulin receptor signaling [50], whereas insulin stimulates clearance and degradation of β-amyloid and thus prevents β-amyloid accumulation in the brain [51-53]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.